Cytokinetics Files 8-K
Ticker: CYTK · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1061983
| Field | Detail |
|---|---|
| Company | Cytokinetics Inc (CYTK) |
| Form Type | 8-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financials
TL;DR
Cytokinetics filed an 8-K, mostly financial docs, no major news.
AI Summary
Cytokinetics, Incorporated filed an 8-K on September 2, 2025, reporting events as of August 30, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text beyond its classification as an 'Other Event'.
Why It Matters
This filing indicates a routine update or submission of financial information and exhibits by Cytokinetics, Inc. to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be a standard regulatory submission without immediate news of significant corporate events.
Key Players & Entities
- CYTOKINETICS INC (company) — Registrant
- 0000950170-25-112564 (filing_id) — Accession Number
- 20250902 (date) — Filing Date
- August 30, 2025 (date) — Report Date
- 350 Oyster Point Boulevard (address) — Principal Executive Offices
- South San Francisco (location) — City
- CA (location) — State
- 94080 (zip_code) — Zip Code
- (650) 624-3000 (phone_number) — Business Phone
FAQ
What is the primary purpose of this 8-K filing?
The filing is a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits' as of August 30, 2025.
When was this 8-K filing submitted to the SEC?
The filing was submitted on September 2, 2025.
What is the exact name of the reporting company?
The exact name of the Registrant is Cytokinetics, Incorporated.
Where are Cytokinetics, Incorporated's principal executive offices located?
The principal executive offices are located at 350 Oyster Point Boulevard, South San Francisco, California, 94080.
What is the SIC code for Cytokinetics, Incorporated?
The Standard Industrial Classification (SIC) code for Cytokinetics, Incorporated is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 449 words · 2 min read · ~1 pages · Grade level 13 · Accepted 2025-09-02 17:20:58
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CYTK The Nasdaq Global Se
Filing Documents
- cytk-20250830.htm (8-K) — 40KB
- cytk-ex99_1.htm (EX-99.1) — 79KB
- img114956760_0.jpg (GRAPHIC) — 23KB
- img114956760_1.jpg (GRAPHIC) — 71KB
- img114956760_2.jpg (GRAPHIC) — 271KB
- 0000950170-25-112564.txt ( ) — 737KB
- cytk-20250830.xsd (EX-101.SCH) — 24KB
- cytk-20250830_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. Cytokinetics, Incorporated announced that the primary results of MAPLE-HCM (Metoprolol vs Aficamten in Patients with LVOT Obstruction on Exercise Capacity in HCM) were presented in a Hot Line Session at the European Society of Cardiology Congress 2025 in Madrid, Spain, and simultaneously published in The New England Journal of Medicine. The full text of the press release issued in connection with this announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. 99.1 Press Release dated August 30, 2025 104 The cover page of this report has been formatted in Inline XBRL
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CYTOKINETICS, INCORPORATED Date: September 2, 2025 By: /s/ John Faurescu SVP, Deputy General Counsel & Secretary